BridgeMD
New treatment option for Atrial Fibrillation
Official title Novel Model of Integrated Care of Older Patients With Atrial Fibrillation to Prevent Heart Failure in Rural China
ClinicalTrials.gov ID: NCT07492498
What this study is testing
- What it's testing
- This cluster randomized study aims to compare village doctor-led integrated care versus usual care to improve cardiovascular health, atrial fibrillation management, self-management adherence, and heart failure prevention among older rural patients with atrial fibrillation in China.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 80
You may be able to join if
- 1\. The village clinics need to be willing and able to provide integrated care to their patients with atrial fibrillation; 2. The village doctors...
- 2)Availability of an electrocardiogram confirming atrial fibrillation, or an official diagnosis certificate of atrial fibrillation issued by a...
- 3)Receiving healthcare management from a primary medical institution near the place of residence.
- 4)Able to understand and sign the informed consent form.
You likely can't join if
- A definite history of heart failure, or confirmed cardiac dysfunction or heart failure based on echocardiography and/or NT-proBNP screening...
- Expected survival of less than 12 months.
- Severe renal insufficiency, defined as creatinine clearance \<30 mL/min, or currently receiving dialysis treatment.
- Cardiac dysfunction caused by reversible secondary causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital...
- Indication for pacemaker implantation but without pacemaker placement.
- Chronic obstructive pulmonary disease complicated by type II respiratory failure.
See the full eligibility criteria
- 1\. The village clinics need to be willing and able to provide integrated care to their patients with atrial fibrillation; 2. The village doctors from one village clinic serves all AF patients from 3-5 nearby villages...
- 2)Availability of an electrocardiogram confirming atrial fibrillation, or an official diagnosis certificate of atrial fibrillation issued by a specialist.
- 3)Receiving healthcare management from a primary medical institution near the place of residence.
- 4)Able to understand and sign the informed consent form.
- A definite history of heart failure, or confirmed cardiac dysfunction or heart failure based on echocardiography and/or NT-proBNP screening. Diagnostic criteria include typical heart failure symptoms or signs with...
- Expected survival of less than 12 months.
- Severe renal insufficiency, defined as creatinine clearance \<30 mL/min, or currently receiving dialysis treatment.
- Cardiac dysfunction caused by reversible secondary causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.
- Indication for pacemaker implantation but without pacemaker placement.
- Chronic obstructive pulmonary disease complicated by type II respiratory failure.
- Special populations, such as patients with mental illness.
The study team makes the final eligibility decision.
Where it's taking place
- Yancheng, Dongtai, China
- Yangzhou, Jiangdu, China
- Xuzhou, Suining, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yancheng, Dongtai, China; Yangzhou, Jiangdu, China; Xuzhou, Suining, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.